T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 4, 2011, Pages 1579-1584

  Corrigan, Chris J ^a   Wang, Wei ^b   Meng, Qiu ^a   Fang, Cailong ^a   Wu, Huifen ^a   Reay, Victoria ^a   Lv, Ze ^b   Fan, Yiqiang ^b   An, Yunqing ^b   Wang, Yui Hsi ^c,d   Liu, Yong Jun ^d   Lee, Tak H ^a   Ying, Sun ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CD31 ANTIGEN; INTERLEUKIN 25; INTERLEUKIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UO 126; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TH2 CELL; UPREGULATION; VASCULAR ENDOTHELIUM;

ADULT; ANTIGENS, CD31; ASTHMA; BLOTTING, WESTERN; BRONCHI; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC MEMORY; INTERLEUKIN-17; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79952136459     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1014241108     Document Type: Article

References (45)

1. Kristan SS, et al. (2009) Airway angiogenesis in patients with rhinitis and controlled asthma. Clin Exp Allergy 39:354-360.
2. Li X, Wilson JW (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156:229-233. (Pubitemid 27293194)
3. Hoshino M, Takahashi M, Aoike N (2001) Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107:295-301. (Pubitemid 32173907)
4. McDonald DM (2001) Angiogenesis and remodelling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164:39-45.
5. Puxeddu I, et al. (2009) The role of eosinophil major basic protein in angiogenesis. Allergy 64:368-374.
6. Detoraki A, et al. (2010) Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 65:946-958.
7. Dong C (2008) Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev 226:80-86.
8. Fort MM, et al. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985-995.
9. Hurst SD, et al. (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25. J Immunol 169:443-453.
10. Pan G, et al. (2001) Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 167:6559-6567. (Pubitemid 33081592)
11. Kim MR, et al. (2002) Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 100:2330-2340.
12. Ballantyne SJ, et al. (2007) Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 120:1324-1331. (Pubitemid 350216590)
13. Angkasekwinai P, et al. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 204:1509-1517. (Pubitemid 47048018)
14. Wang YH, et al. (2007) IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med 204:1837-1847.
15. Ikeda K, et al. (2003) Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 101:3594-3596. (Pubitemid 36857947)
16. Wong CK, Cheung PF, Ip WK, Lam CW (2005) Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 33:186-194. (Pubitemid 41473056)
17. Lajoie-Kadoch S, et al. (2006) TNF-alpha and IFN-gamma inversely modulate expression of the IL-17E receptor in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290:L1238-L1246. (Pubitemid 43830869)
18. Caruso R, et al. (2009) Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. Blood 113:3512-3519.
19. Létuvé S, et al. (2006) IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 117:590-596. (Pubitemid 43340223)
20. Meng Q, et al. (2009) IL-25 and its receptor (IL-25R) in allergic inflammation: Its role in VEGF-mediated angiogenesis. J Allergy Clin Immunol 123:S58 [abs 209].
21. Kang CM, et al. (2005) Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 33:290-296.
22. Wang YH, Liu YJ (2009) Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy 39:798-806.
23. Imaizumi T, et al. (2000) Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha. Arterioscler Thromb Vasc Biol 20:410-415. (Pubitemid 30086097)
24. Lei JT, Martinez-Moczygemba M (2008) Separate endocytic pathways regulate IL-5 receptor internalization and signaling. J Leukoc Biol 84:499-509.
25. Zimmermann N, Conkright JJ, Rothenberg ME (1999) CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem 274:12611-12618.
26. Roussel L, et al. (2010) IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 184:4531-4537.
27. Rickel EA, et al. (2008) Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 181:4299-4310.
28. Wong CK, Li PW, Lam CW (2007) Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes. Immunol Lett 112:82-91. (Pubitemid 47379851)
29. Maezawa Y, et al. (2006) Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 176:1013-1018. (Pubitemid 43099701)
30. Claudio E, et al. (2009) The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol 182:1617-1630.
31. Swaidani S, et al. (2009) The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol 182:1631-1640.
32. Choi YK, et al. (2010) Carbon monoxide promotes VEGF expression by increasing HIF-1α protein level via two distinct mechanisms, translational activation and stabilization of HIF-1α protein. J Biol Chem 285:32116-32125.
33. Weylie B, Zhu J, Singh U, Ambrus S, Forough R (2006) Phosphatidylinositide 3-kinase is important in late-stage fibroblast growth factor-1-mediated angiogenesis in vivo. J Vasc Res 43:61-69. (Pubitemid 41832708)
34. Wang Z, Jiang C, Ganther H, Lü J (2001) Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Cancer Res 61:7171-7178. (Pubitemid 32946511)
35. Takeda M, et al. (2010) The pathophysiological roles of PI3Ks and therapeutic potential of selective inhibitors in allergic inflammation. Int Arch Allergy Immunol 152(Suppl 1):90-95.
36. Issbrücker K, et al. (2003) p38 MAP kinase - a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J 17:262-264.
37. Simcock DE, et al. (2007) Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med 176:146-153. (Pubitemid 47057850)
38. Bailey SR, et al. (2009) Airway vascular reactivity and vascularisation in human chronic airway disease. Pulm Pharmacol Ther doi:10.1016.
39. Ying S, et al. (2005) Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 174:8183-8190. (Pubitemid 40806330)
40. Ying S, et al. (2008) Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 181:2790-2798.
41. Lin CM, et al. (2006) Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol 6:1690-1698.
42. Abid MR, et al. (2004) Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IκB-NF-κB. J Bio Chem 279:44030-44038.
43. Ye M, et al. (2008) Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest Ophthalmol Vis Sci 49:497-504.
44. Benko S, Magalhaes JG, Philpott DJ, Girardin SE (2010) NLRC5 limits the activation of inflammatory pathways. J Immunol 185:1681-1691.
45. Fujii T, Wakaizumi M, Ikami T, Saito M (2008) Amla (Emblica officinalis Gaertn.) extract promotes procollagen production and inhibits matrix metalloproteinase-1 in human skin fibroblasts. J Ethnopharmacol 119:53-57.